<?xml version="1.0" encoding="utf-8"?><svg:svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svg="http://www.w3.org/2000/svg" version="1.1" width="595.22px" height="842px" preserveAspectRatio="none" viewBox="0 0 595.22 842"><svg:defs><svg:clipPath id="--clippath0" transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:clipPath><svg:style type="text/css">@font-face { font-family: "g_d0_f1";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f2";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f3";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f4";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f5";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f6";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f7";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f8";; src: url(data:font/woff;base64,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); } </svg:style></svg:defs><svg:g transform="matrix(1 0 0 -1 0 842)"><svg:g transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:g><svg:g clip-path="url(#clippath0)"><svg:g transform=""><svg:text transform="matrix(7.5 0 0 7.5 37.7953 52.9521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.556 1.112" font-family="g_d0_f1" font-size="1px" fill="rgb(43,46,52)">280</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 37.7953 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.677 0.847 1.161 1.499 1.985 2.323 2.682 3.204 3.705 4.225 4.922 5.444 5.966 6.488 6.989" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)">Ultrarresúmenes </svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 118.523 787.491) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.235" x="0 1.062 2.149" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)">DAE</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 151.402 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.35 0.865 1.351 1.689 2.175 2.525 2.695 3.181 3.531 4.046 4.405 4.927 5.442 5.928 6.266 6.752 7.186 7.368 7.885 8.407 8.757 9.262 9.784 10.134 10.651 11.166 11.683 12.184 12.366 12.8 12.982 13.499 14.021 14.543" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)"> para la preparación de oposiciones</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 624.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.556 1.056 1.389 1.889 2.333 2.611 3.333 3.833 4.333 4.611 4.889 5.389 5.889 6.611 6.889 7.611 8.111 8.389 8.667 9.167 9.667 10.111 10.333 10.833 11.055 11.555 12.055 12.333 12.611 13.111 13.611 13.944 14.444 14.722 15.222 15.722" font-family="g_d0_f4" font-size="1px" fill="rgb(61,68,70)">Parasimpaticomiméticos o colinérgicos</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 602.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 602.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.172 1.45 1.672 2.339 2.783 3.005 3.449 3.893 4.115 4.559 4.781 5.059 5.503 5.947 6.225 6.669 7.113 7.557 7.946 8.39 8.834 9.056 9.278 9.722 10.111 10.333 10.777 11.055 11.499 11.888 12.166 12.61 12.999 13.221 13.665 13.943 14.387 14.776 15.22 15.609 16.053 16.497 16.941 17.33 17.552 17.996 18.44 18.718 18.94 19.162 19.606 19.828 20.272 20.661 20.939 21.161 21.828 22.272 22.494 22.938 23.327 23.549 23.993 24.437 24.659 25.103 25.547 25.825 26.269 26.658 26.88 27.547 27.991 28.435 28.713 28.935 29.324 29.768 29.99" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Estimulan o reproducen los efectos provocados por la estimulación parasimpática. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.005 1.227 1.671 2.115 2.559 2.837 3.281 3.559 3.837 4.281 4.725 5.114 5.781 6.003 6.392 6.836 7.114 7.336 7.558 7.78 8.224 8.668 8.946 9.39 9.834 10.278 10.5 10.944 11.333 11.555 11.777 12.221 12.443 12.887 13.276 13.72 13.998 14.22 14.442 14.831 15.275 15.497 15.719 16.163 16.607 16.829 17.051 17.495 17.939 18.383 18.605 19.049 19.438 19.716 20.16 20.604 20.826 21.215 21.659 22.103 22.381 22.825 23.047 23.491 23.935 24.324 24.546 24.824 25.046 25.49 25.934 26.323 26.545 26.989 27.433 27.655 27.933 28.377 28.766 29.21 29.654 29.932 30.376 30.654 31.098 31.487" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> El neurotransmisor liberado es la acetilcolina, que actúa sobre dos tipos de receptores:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 580.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9453 1.7233 2.1673 2.5563 2.9453 3.3893 3.6673 3.8893 4.3333 4.5553 4.9443 5.3883 5.7773 5.9993 6.2586 6.6476 7.0916 7.4806 7.9246 8.3686 8.5906 8.8126 9.2566 9.5346 9.9786 10.3676 10.5896 11.0336 11.4776 11.6996 11.9589 12.4029 12.6809 13.1249 13.5689 13.7909 14.1799 14.6239 14.9019 15.3459 15.5679 16.0119 16.2339" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- Muscarínicos: vasodilatación, bradicardia, </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 213.625798 580.1362) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.299" x="0" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">↑</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 219.053698 580.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.4442 0.8882 1.1102 1.5542 1.8134 2.2024 2.6464 3.0904 3.5344 3.9784 4.2004 4.6444 5.0884 5.5324 5.7544 6.0136 6.4576 6.7356 7.1796 7.6236 8.0126 8.4566 8.8456 9.2896 9.7336 10.1226 10.4006 10.6786 10.9006 11.2896 11.6786 11.9006 12.3446 12.7886 13.0106 13.2698 13.9368 14.1588 14.6028 14.9918 15.2138 15.6028 15.8248 16.084 16.528 16.972 17.639 18.083 18.527 18.805 19.249 19.5082 19.9522 20.3962 20.6554 21.0444 21.4884 21.8774 22.1554 22.5994 22.9884 23.2104 23.6544 24.0984 24.5424 24.9314 25.1906 25.6346 26.0786 26.4676 26.7456 27.0236 27.2456 27.6346 28.0786 28.4676 28.6896 28.9488 29.3928 29.8368 30.096 30.374 30.818 31.262 31.706 31.9652 32.3542" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">ﬂ ujo sanguíneo, broncoconstricción, miosis, aumento en secreciones gástricas, en tono y </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.700096 569.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.11 1.332 1.776 2.22 2.498 2.72 3.109 3.387 3.831 4.053 4.331 4.553 4.942 5.609 6.053" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">del peristaltismo.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.195997 558.838599) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.556 1.778 2.167 2.611 2.889 3.111 3.555 3.777 4.166 4.61 4.999 5.221 5.443 5.665 5.887 6.331 6.775 7.053 7.497 7.886 8.108 8.552 8.996 9.218 9.662 10.106 10.328 10.884 11.44 11.996 12.218 12.44 12.884 13.106 13.55 13.828 14.272 14.55 14.994 15.383 15.605 15.994 16.216 16.438 16.827 17.271 17.66 18.104 18.548 18.77 18.992 19.436 19.714 20.158 20.547 20.769 21.213 21.657 21.879 22.268 22.712 22.99 23.434 23.878 24.322 24.6 24.822 25.266 25.488 25.71 26.377 26.599 27.043 27.321 27.543 27.987 28.376 28.598 28.987 29.209 29.598 29.82 30.098 30.542 30.931 31.32 31.542 31.931 32.375 32.597 33.041 33.43 33.652 34.096 34.54 34.984 35.373 35.595 36.262 36.706 37.095 37.484 37.928 38.15 38.594 38.872 39.316 39.705" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- Nicotínicos: liberación de ADH, diaforesis, vasodilatación coronaria, midriasis y fasciculaciones musculares.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 349.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(0,184,241)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 58.6909 349.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.556 1.056 1.389 1.889 2.333 2.611 3.333 3.833 4.333 4.611 4.889 5.389 5.889 6.167 6.445 6.723 7.001 7.501 8.001 8.445 8.667 9.167 9.389 9.889 10.389 10.667 10.945 11.445 11.945 12.223 12.501 13.001 13.501 13.834 14.334 14.612 15.112 15.612" font-family="g_d0_f4" font-size="1px" fill="rgb(61,68,70)">Parasimpaticolíticos o anticolinérgicos</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 327.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 327.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.561 1.005 1.449 1.671 2.115 2.559 3.003 3.225 3.669 3.891 4.335 4.557 5.001 5.445 5.889 6.333 6.777 7.221 7.443 7.665 8.109 8.331 8.775 9.164 9.442 9.664 10.053 10.275 10.719 11.163 11.607 11.829 12.273 12.717 12.995 13.439 13.828 14.05 14.717 15.161 15.605 15.883 16.105 16.494 16.938 17.16" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Inhiben o bloquean la actividad parasimpática. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 316.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 316.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3384 0.8384 1.2824 1.5308 1.9198 2.3638 3.0308 3.4748 3.9188 4.1968 4.4748 4.9188 5.3628 5.6112 6.0002 6.4442 7.1112 7.5552 7.8036 8.2476 8.6916 8.9696 9.4136 9.8576 10.3016 10.7456 10.9676 11.3566 11.6346 12.0786 12.4676 12.716 13.105 13.549 14.216 14.66 15.104 15.382 15.604 15.882 16.104 16.493 16.937 17.326 17.5744 18.0184 18.4624 18.7108 18.9328 19.3768 19.6252 20.0692 20.4582 20.9022 21.1802 21.4022 21.6242 22.0132 22.4572 22.6792 22.9012 23.3452 23.7892 24.0376 24.3156 24.5936 25.0376 25.4816 25.7596 26.2036 26.452 26.896 27.1444 27.3664 27.8104 28.1994 28.4478 28.7258 29.1698 29.5588 30.0028 30.4468 30.7248 31.1688 31.4468 31.8908 32.2798 32.5282 33.1952 33.6392 34.0282 34.4172 34.8612 35.1392 35.3612 35.8052 36.0272 36.4162 36.8602 37.2492 37.4976 37.9416 38.3856 38.8296 39.078 39.467 39.911 40.1594 40.6034 41.0474 41.4364 41.8804 42.3244 42.7684 43.0464 43.3244 43.7684 44.2124 44.4608 44.9048 45.3488 45.5972 45.8192 46.2632 46.6522 46.9006" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Se comportan como antagonistas competitivos de la acetilcolina frente a los receptores muscarínicos que se encuentran en los ó</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 488.249991 316.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 1.166 1.61 2.054 2.443" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">rganos </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196879 305.8383) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.11 1.388 1.777 2.221 2.665 3.109 3.498 3.72 4.164 4.608 4.886 5.108 5.33 5.774 6.163 6.385 6.607 6.829 7.273 7.551 7.995 8.384 8.606 9.05 9.494 9.883 10.161 10.605 11.049 11.493 11.937 12.159 12.381 12.825 13.269 13.713 13.991 14.435 14.824" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">inervados por las ﬁ bras postganglionares.</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7275 743.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.778 1.278 1.778 2.056 2.556 3 3.222 3.666 4.166 4.666 5.166 5.666 6.166 6.666 6.999 7.221 7.721" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Efectos secundarios</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.767 743.9235) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.778 1.222 1.666 1.888 2.277 2.721 2.999 3.443 3.665 4.109 4.331 4.553 4.997 5.219 5.663 6.107 6.385 6.829 7.273 7.662 7.884 8.328 8.772 8.994 9.438 9.66 10.104 10.548 10.992 11.436 11.88 12.102 12.658 12.936 13.336 13.558 13.78 14.002 14.446 14.835 15.279 15.501 15.723 16.112 16.334 16.778 17.222 17.611 17.833 18.277 18.499 18.888 19.332 19.61 20.054 20.276 20.72 21.109 21.553 21.775 22.164 22.608 23.052 23.496 23.94 24.329 24.607 24.829 25.218 25.662 25.884 26.106 26.495 26.939 27.383 27.661 28.105 28.327 28.605 29.049 29.493 29.937 30.159 30.603 31.047 31.269 31.713 32.157 32.546 32.768 33.212 33.656 33.934 34.378 34.767 34.989 35.378 35.822 36.266" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Bradicardia, hipotensión bloqueo A-V, insuﬁ ciencia cardiaca congestiva (sobre todo en pacientes con </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.767 733.7235) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.667 1.111 1.333 1.777 1.999 2.277 2.721 3.165 3.554 3.776 4.22 4.664 4.886 5.275 5.719 6.163 6.441 6.719 6.941 7.33 7.774 7.996 8.44 8.718 8.94 9.384 9.662 10.106 10.495 10.717 11.161 11.383 11.605 11.827 12.105 12.549 12.827 13.049 13.493 13.937 14.159 14.381 14.825 15.269 15.713 15.991 16.435 16.824 17.046 17.49 17.934 18.156 18.378 18.822 19.266 19.655 20.099 20.543 20.765 20.987 21.209 21.653 22.042 22.264 22.653 22.875 23.319 23.763 23.985 24.263 24.707 25.096 25.318 25.762 26.206 26.428 26.65 27.094 27.538 27.982 28.371 28.815 29.259 29.648 29.87 30.092 30.481 30.925 31.592 31.814 32.092 32.536 32.925 33.147 33.369 33.813 34.035 34.479 34.757 35.035 35.479 35.923 36.145 36.534 36.756 36.978 37.422 37.811 38.255" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">mala función ventricular previa), fatiga, depresión, pesadillas y agitación, náuseas, vómitos, diarrea y leve </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.767 723.5235) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.11 1.499 1.943 2.332 2.554 2.998 3.442 3.664 4.108 4.552 4.774 5.052 5.33 5.774 6.218 6.607 7.051 7.718 7.94 8.384 8.828 9.217 9.661 10.05 10.272 10.494 10.938 11.216 11.66 12.104 12.493 12.937 13.381 13.77 14.214 14.658 15.047 15.714 16.158 16.38 16.602 17.046 17.435 17.879 18.323 18.712 18.934 19.378 19.6 20.267 20.711 21.155 21.433 21.877 22.099 22.543 22.987 23.209 23.653 24.097 24.486 24.708 25.152 25.596 25.874 26.318 26.707 26.929 27.318 27.762 28.206 28.428 28.872 29.094 29.538 29.982 30.26 30.538 30.982 31.426 31.815 32.093 32.315 32.704 32.926 33.37 33.814 34.258 34.48 34.924 35.202 35.646 36.09 36.534 36.978 37.2 37.644 37.866 38.088" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">elevación de transaminasas, broncoespasmo, especialmente en pacientes con hiperreactividad bronquial, </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.767 713.3235) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.667 0.889 1.333 1.555 1.999 2.221 2.665 3.054 3.276 3.665 3.887 4.331 4.775 4.997 5.441 5.719 6.163 6.552 6.774 7.441 7.885 8.274 8.663 9.107 9.329 9.773 10.217 10.606 11.05 11.494 11.938 12.16 12.604 12.882 13.104 13.493 13.937 14.326 14.548 14.77 14.992 15.659 16.103 16.547 16.825 17.269 17.713 18.102 18.324 18.768 18.99 19.212 19.656 19.878 20.267 20.934 21.156 21.6 22.044 22.433 22.655 23.099 23.543 23.765 24.209 24.653 24.875 25.097 25.541 25.763 25.985 26.207 26.651 26.873 27.317 27.761 27.983 28.205 28.649 28.927 29.371 29.815 30.204 30.426 30.87 31.314 31.758 32.147 32.369 32.758 33.202 33.48 33.924 34.368 34.812 35.256" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">mialgias y dolores musculoesqueléticos, impotencia, disminución de la libido, erupciones cutáneas</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7275 698.4535) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.056 1.556 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Interacciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.767 698.5385) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.834 1.112 1.556 1.945 2.167 2.611 2.833 3.277 3.721 3.999 4.443 4.887 5.276 5.72 5.998 6.442 6.831 7.053 7.275 7.738 8.182 8.46 8.904 9.348 9.792 10.459 10.681 10.903 11.347 11.569 11.791 12.235 12.457 12.679 12.957 13.179 13.623 13.956 14.4 14.844 15.066 15.51 15.732 16.121 16.565 17.009 17.231 17.675 18.119 18.341 18.785 19.063 19.285 19.729 20.007 20.285 20.729 20.951 21.395 21.839 22.117 22.339 22.783 23.061 23.339 23.561 23.839 24.506 24.728 25.117 25.561 25.783 26.005 26.561 27.005 27.227 27.671 28.115 28.559 28.837 29.059 29.503 29.947 30.169 30.391 30.78 31.002 31.28 31.724 32.168 32.612 32.89 33.112 33.556 33.889 34.111 34.555 34.999 35.388 35.61" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Otros hipotensores. Verapamilo, diltiazen o cualquier otro antiarrítmico. Haloperidol y fenotiazinas. </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.767 688.3385) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.278 1.5 1.944 2.388 2.832 3.11 3.554 3.943 4.165 4.554 4.998 5.387 5.609 5.831 6.331 6.553 6.997 7.441 7.885 8.329 8.773 9.217 9.495 9.939 10.161 10.605 11.049 11.493 11.771 12.215 12.882 13.326 13.715 14.104 14.548 14.77 15.214 15.492 15.936 16.325 16.547 16.769 17.213 17.491 17.935 18.379 18.657 19.101 19.768 19.99 20.434 20.878 21.1 21.322 21.711 22.155 22.377 22.766 22.988 23.655 24.099 24.377 24.599 25.043 25.265 25.709 26.153 26.375 26.819 27.263 27.93 28.374 28.818 29.096 29.54 29.762 29.984 30.428 30.817 31.039 31.483 31.705 32.094 32.538 32.76 33.204 33.593 33.815 34.259 34.703 34.925 35.369 35.647 36.091 36.535 36.979 37.423 37.867 38.089 38.311" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Antidepresivos. Bloqueante neuromusculares. Ergotamina. La cimetidina aumenta los niveles de propanol. </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.767 678.1385) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.778 1.389 1.833 2.055 2.277 2.647 3.091 3.535 3.757 3.979 4.201 4.423 4.867" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">AINE. Teoﬁ lina</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.727904 663.2686) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.889 1.389 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111 5.555" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Precauciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.727904 653.0686) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.944 1.444 1.944 2.444 2.666 3.166 3.388 3.888" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">especiales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.767 663.3536) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.778 1.222 1.666 1.944 2.222 2.666 3.11 3.499 3.721 4.165 4.609 4.831 5.275 5.719 5.997 6.275 6.719 6.941 7.163 7.385 7.941 8.385 8.829 9.273 9.551 9.995 10.384 10.606 11.05 11.494 11.938 12.327 12.605 13.049 13.438 13.66 14.049 14.493 14.882 15.104 15.326 15.77 16.159 16.548 16.992 17.381 17.825 18.047 18.325 18.769 19.158 19.602 19.88 20.269 20.713 20.935 21.324 21.768 22.046 22.49 22.712 23.156 23.545 23.989 24.211 24.433 24.822 25.266 25.488 25.932 26.21 26.654 27.098 27.32 27.709 28.153 28.431 28.875 29.097 29.541 29.763 30.207 30.485 30.929 31.318 31.762 32.151 32.595 33.039 33.483 33.705 34.149 34.593 34.871 35.093 35.537 35.759" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Hipertensión portal. Agentes anestésicos. Escasa reserva cardiaca. La bradicardia provocada por el </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.767 653.153599) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.722 1.166 1.61 2.054 2.498 2.942 3.164 3.608 3.83 4.052 4.33 4.774 5.441 5.663 5.941 6.385 6.607 6.996 7.44 7.884 8.106 8.55 8.994 9.438 9.66 9.938 10.382 10.826 11.27 11.659 12.048 12.27 12.714 13.158 13.38 13.824 14.268 14.49 14.712 15.156 15.378 15.822 16.266 16.655 16.877 17.266 17.488 17.932 18.154 18.543 18.987 19.431 19.653 19.875 20.319 20.541 20.93 21.374 21.818 22.096 22.54 22.929 23.151 23.595 24.039 24.261 24.539 24.983 25.261 25.705 25.927 26.149 26.371 26.76 26.982 27.204 27.593 28.037 28.259 28.703 28.981 29.425 29.814 30.036 30.425" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">propanolol remite con una reducción de la dosis o con la supresión total, si se precisa</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 72.9111 760.6337) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.739 8.093 8.637 9.176 9.688 10.236 10.78 10.992 11.536 11.748" font-family="g_d0_f8" font-size="1px" fill="rgb(64,198,192)">Principio activo: propanolol </svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 188.114754 760.5007) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.226 0.66 1.177 1.699 2.013 2.195 2.717 3.237 3.723 4.157 4.339 4.856 5.378" font-family="g_d0_f2" font-size="1px" fill="rgb(64,198,192)">(continuación)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7087 525.2525) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.778 1.278 1.722 1.9213 2.4213 2.9213 3.1206 3.6206 4.1206 4.8426 5.0646 5.5646 5.7866 6.2306 6.5086 6.8416 7.3416 7.8416 8.0636 8.5636" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Vías de administración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 525.3385) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.212 0.646 0.914 1.182 1.616 1.995 2.429 2.863 3.297 3.676" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Intravenosa</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7087 507.5365) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.555 1.777 2.221 2.443 2.943 3.443 3.943 4.165 4.443 4.943 5.443 5.665 6.165" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Dosis habituales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 507.6215) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.333 1.777 1.999 2.221 2.665 2.943 3.221 3.665 4.054 4.498 4.942 5.386 5.775 6.219 6.441 6.663 6.885 7.329 7.773 8.051 8.495 8.717 8.939 9.383 9.827 10.049 10.327 10.605 11.049 11.438 11.66 12.327 12.549 12.993 13.437 13.715 14.159 14.548 14.77 14.992 15.214 15.714 16.158 16.38 16.824 17.268 17.712 18.156 18.6 18.822 19.1 19.544 19.988 20.432 20.71 20.932 21.21 21.432 21.821 22.265 22.709 23.153 23.375 23.819 24.041 24.485 24.818 25.04 25.707 25.929 26.373 26.817 27.095 27.539 27.928 28.15 28.594 29.038 29.427 29.705 30.149 30.371 30.815 31.259 31.481 32.148 32.592 32.981 33.203 33.87 34.314 34.536 34.98 35.424 35.646 36.09 36.312 36.979" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">1 mg intravenosa (lento, en tres minutos). Se puede repetir cada diez minutos hasta un máximo de 4 mg</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7087 491.9455) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.278 1.5 2 2.5 3 3.222 3.722 4.222 4.722" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Indicaciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 492.0315) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 0.944 1.388 1.777 1.999 2.388 2.832 3.221 3.443 3.887 4.331 4.553 4.942 5.386 5.775 6.219 6.497 6.941 7.163 7.607 8.051 8.329 8.551 8.995 9.439 9.717 9.939 10.328 10.772 10.994 11.216 11.66 12.104 12.382 12.826 13.048 13.437 13.881" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Intoxicación severa por anticolinérgicos</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7087 477.1615) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 1.833 2.333" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Acción</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 477.2465) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.278 1.722 2.166 2.61 3.054 3.276 3.609 4.053 4.275 4.497 4.941 5.33 5.552 5.996 6.274 6.718 7.107 7.385 7.829 8.218 8.44 8.884 9.328 9.55 9.772 10.216 10.605 10.827 11.271 11.715 11.993 12.215 12.604 13.048 13.27 13.492 13.936 14.38 14.658 15.102 15.324 15.713 16.157 16.546 16.768 17.046 17.49 17.934 18.212 18.656 18.878 19.322 19.766 19.988 20.432 20.654 20.876 21.265 21.487 21.876 22.154 22.598 23.265 23.709 23.931 24.375 24.819 25.097 25.486 25.708 26.152 26.541 26.985 27.207 27.651 28.095 28.373 28.595 28.873 29.317 29.595 29.817 30.206 30.65 30.872 31.261 31.705 32.372 32.816 33.038 33.482 33.926 34.148 34.592 34.814 35.036 35.425 35.869 36.313 36.591 36.869 37.313 37.535 37.757 37.979 38.368 38.812" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Antagoniza los efectos de los anticolinérgicos tanto en el sistema nervioso periférico como en el central, ya </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 467.0465) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.332 1.554 1.998 2.276 2.554 2.998 3.387 3.609 4.053 4.442 4.886 5.108 5.33 5.774 5.996 6.44 6.884 7.162 7.44 7.884 8.162 8.606 8.828 9.272 9.716 10.383 10.827 11.105 11.549 11.993 12.437 12.826 13.27 13.548 13.992 14.214 14.436 14.825" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">que atraviesa la barrera hematoencefálica</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7087 452.1765) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.778 1.278 1.778 2.056 2.556 3 3.222 3.666 4.166 4.666 5.166 5.666 6.166 6.666 6.999 7.221 7.721" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Efectos secundarios</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 161.748 451.755) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)"></svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 167.202 451.8655) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.722 0.944 1.388 1.832 2.11 2.554 3.221 3.665 3.887 4.276 4.72 4.942 5.164 5.608 6.052 6.33 6.774 6.996 7.385" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Síndrome colinérgico</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 161.748 440.955) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 169.2 441.0655) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.722 0.944 1.166 1.61 1.832 2.276 2.72 3.387 3.609 4.053 4.275 4.664 4.942 5.22 5.664 6.053 6.275 6.719 7.163 7.385 7.607 8.051 8.329 8.607 9.051 9.44 9.884 10.328 10.772 11.161 11.605 11.827 12.216 12.66 12.882 13.326 13.77 14.159 14.603 14.825 15.103 15.547 15.991 16.213 16.657 17.101 17.323 17.545 17.989 18.267 18.711 19.155 19.377 19.766 20.21 20.488 20.932 21.154 21.598 21.82 22.042 22.486 22.708 22.93 23.152 23.541 23.985 24.207 24.485 24.929 25.373 25.595 25.873 26.317 26.706 27.15 27.372 27.65 28.094 28.372 28.816 29.094 29.316 29.76 29.982 30.204 30.648 30.87 31.314 31.758 32.036 32.425 32.869 33.091 33.313 33.702 34.146 34.535 34.757 35.201 35.645 35.867 36.256" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Si la administración intravenosa se hace rápida: bradicardia, diﬁ cultad respiratoria, hipersalivación y </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 170.2523 430.8655) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.277 1.666 2.11 2.332 2.721 2.943 3.387 3.831 4.275 4.664" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">convulsiones </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 161.748 419.955) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 169.2 420.0655) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.388 1.777 2.221 2.443 2.832 3.054 3.498 3.942 4.386 4.775 4.997 5.386 5.608 6.052 6.441 6.663 7.052 7.33 7.774 7.996 8.218 8.662 8.884 9.106 9.55 9.772 10.216 10.438 10.716 11.16 11.549 11.771 12.215 12.659 13.048 13.27" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Convulsiones y asistolia, a altas dosis</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7087 405.2465) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.056 1.556 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Interacciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 405.3315) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.611 1.055 1.277 1.721 2.11 2.554 2.943 3.165 3.609 3.887 4.109 4.553 4.775 5.053 5.497 5.719 6.163 6.385 6.829 7.273 7.551 7.995 8.384 8.606 9.273 9.717 10.106 10.495 10.939 11.161 11.605 11.883 12.327 12.716 12.938 13.382 13.826 14.215 14.659 15.103 15.325 15.769 16.047 16.269 16.602 17.046 17.49 17.768 18.212 18.601 18.823 19.045 19.489 19.933 20.211 20.655 21.099 21.488 21.71 22.154 22.376 22.82 23.264 23.486 23.93 24.319 24.763 25.207 25.596 25.818 26.207 26.429 26.707 27.151 27.373 27.817 28.039 28.483 28.927 29.205 29.649 30.038 30.26 30.704 31.148 31.537 31.981 32.425 32.647 33.091 33.369 33.591 33.924 34.368 34.812 35.09 35.534" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">No asociar a relajantes musculares despolarizantes, potencia opiáceos y relajantes despolarizantes</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.708904 387.407549) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.889 1.389 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111 5.555" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Precauciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.708904 377.207549) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.944 1.444 1.944 2.444 2.666 3.166 3.388 3.888" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">especiales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 387.493399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.667 1.889 2.333 2.555 2.944 3.222 3.5 3.944 4.333 4.555 4.999 5.443 5.665 5.887 6.331 6.775 7.053 7.497 7.719 7.941 8.552 8.996 9.218 9.885 10.329 10.662 11.051 11.273 11.717 11.995 12.217 12.606 13.05 13.494 13.716 14.16 14.438 14.716 15.16 15.382 15.66 16.104 16.382 17.049 17.493 17.882" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Administración lenta. No mezclar con otro fármaco</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 72.9111 541.657) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.52 7.736 8.276 8.82 9.36 9.698 9.914 10.444 11.169 11.385 11.933" font-family="g_d0_f8" font-size="1px" fill="rgb(64,198,192)">Principio activo: fisostigmina</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7086 267.3005) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.778 1.278 1.722 1.9213 2.4213 2.9213 3.1206 3.6206 4.1206 4.8426 5.0646 5.5646 5.7866 6.2306 6.5086 6.8416 7.3416 7.8416 8.0636 8.5636" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Vías de administración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 267.3855) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.212 0.646 0.914 1.182 1.616 1.995 2.429 2.863 3.297 3.676 4.11 4.322 4.534 4.968 5.402 5.836 6.27 6.538 6.806 7.24 7.674 8.108 8.542 8.976" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Intravenosa, endotraqueal</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7086 249.5835) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.555 1.777 2.221 2.443 2.943 3.443 3.943 4.165 4.443 4.943 5.443 5.665 6.165" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Dosis habituales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 161.748 249.163) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 169.2 249.2735) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.944 1.444 1.666 1.888 2.277 2.721 3.165 3.609 3.831 4.109 4.331 4.775 4.997 5.441 5.885 6.163 6.385 6.663 7.33 7.774 8.163 8.385 8.607 9.051 9.44 9.662 10.051 10.329 10.773 10.995 11.217 11.661 11.883 12.327 12.549 13.105 13.549 14.327 14.549 14.827 15.271 15.493 15.882 16.326 16.715 16.937 17.381 17.77 17.992 18.436 18.88 19.102 19.546 19.768 20.212 20.601 20.879 21.157 21.601 22.268 22.712 23.101 23.545 23.989 24.211 24.6 25.044 25.322 25.544 25.766 25.988 26.432 26.876 27.265 27.487 27.876 28.098 28.542 28.986 29.208 29.597 30.041 30.263 30.707 31.151 31.373 31.817 32.039 32.706 33.15 33.372 33.594 34.038 34.26 34.927 35.371 35.593 36.037 36.481 36.759 36.981 37.37 37.592 38.036" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">PCR: seguir algoritmos (asistolia o DEM -disociación electromecánica-), dosis única de 3 mg (6 mg por vía </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 170.2523 239.0735) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.556 1 1.444 1.888 2.332 2.776 2.998 3.22 3.442 3.664 4.108 4.552 4.774 4.996 5.44 5.829 6.051 6.44 6.884 7.273 7.717 8.106 8.328 8.772 9.216 9.438 9.994 10.438 11.216 11.438 11.882 12.326 12.993 13.215 13.659 13.881 14.27 14.548 14.826 15.27 15.548 15.77 16.159 16.603 16.825 17.269 17.491 17.88 18.102 18.324 18.546 18.99 19.212 19.49 19.768 20.212 20.601 21.045 21.489 21.933 22.322 22.544 22.988 23.21 23.654 24.098 24.376 24.82 25.209 25.487 25.931 26.375 26.819 27.041 27.485 27.874 28.096 28.763 29.207 29.651 30.095 30.373 30.595 31.039 31.483 31.927 32.149 32.593 33.037 33.259 33.481 33.925 34.203 34.425 34.869 35.313 35.702 36.035 36.702 36.924 37.368 37.812 38.09" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">traqueal). En los casos de DEM administrar solo si la frecuencia detectada es menor que 60 latidos/minuto</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 161.748 228.163) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 169.2 228.2735) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.778 1.222 1.666 1.888 2.277 2.721 2.999 3.443 3.665 4.109 4.331 4.553 4.942 5.386 5.83 6.274 6.496 6.774 6.996 7.44 7.662 8.106 8.55 8.828 9.05 9.328 9.995 10.439 10.828 11.05 11.272 11.494 11.938 12.16 12.549 12.771 13.215 13.493 13.715 14.104 14.548 14.992 15.214 15.658 15.88 16.324 16.546 17.213 17.657 17.879 18.101 18.545 18.823 19.101 19.545 19.934 20.378 20.822 21.266 21.655 22.099 22.488 22.71 22.932 23.395 23.839 24.061 24.505 24.783 25.227 25.505 25.727 26.005 26.449 26.838 27.282 27.726 28.17 28.559 28.837 29.281 29.503 29.725 30.169 30.613 30.835 31.113 31.557 32.001 32.39 32.612 33.056 33.5 33.722 34.166 34.61 34.832 35.054 35.498" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Bradicardia: seguir algoritmos. Iniciar con 0,5 mg intravenosos. Valorar respuesta. En función de la </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 170.2523 218.0735) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 1.111 1.555 1.999 2.443 2.832 3.11 3.554 3.776 3.998 4.276 4.72 5.164 5.608 5.886 6.108 6.386 6.608 7.052 7.496 7.885 8.107 8.496 8.718 9.162 9.606 9.828 10.272 10.494 10.938 11.16 11.827 12.271 12.493 12.937 13.381 13.77 14.048 14.492 14.714 15.158 15.602 15.824 16.491 16.935 17.324 17.546 18.213 18.657 18.879 19.323 19.767 19.989 20.433 20.655 21.322 21.766 21.988 22.432 22.654 23.098 23.32 23.764 24.208 24.43 24.874 25.541 25.985 26.207 26.651 27.095 27.373 27.595 28.262 28.706 28.984 29.373 29.817 30.261 30.705 31.094 31.538" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">respuesta, repetir dosis de 0,5 mg hasta un máximo de 3 mg o bien emplear marcapasos</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7086 203.2545) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.278 1.5 2 2.5 3 3.222 3.722 4.222 4.722" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Indicaciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 203.3396) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.778 1.222 1.666 1.888 2.277 2.721 2.999 3.443 3.665 4.109 4.331 4.72 4.942 5.386 5.664 6.108 6.775 7.219 7.497 7.719 8.108 8.552 8.774 8.996 9.44 9.662 10.106 10.55 10.994 11.438 11.882 12.104 12.548 12.992 13.27 13.492 13.881 14.325 14.547 14.991 15.269 15.658 16.102 16.546 16.824 17.102 17.324 17.713 18.157 18.379 18.823 19.031 19.253 19.475 19.919 20.308 20.53 20.919 21.197 21.641 21.863 22.085 22.529 22.751 22.973 23.195 23.639 23.917 24.361 24.75 24.972 25.361 25.805 26.194 26.416 26.86 27.304 27.526 27.97 28.414 28.692 28.914 29.358 29.636 30.08 30.524 30.968 31.412 31.69 32.134 32.523 32.801 33.245 33.523 33.967 34.411 34.855 35.244 35.466 35.688 35.91 36.354 36.798 37.242 37.631 38.02 38.242 38.686 39.13" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Bradicardia sintomática, bloqueo aurículo-ventricular, asistolia, intoxicación por organofosforados, inducción </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 193.1396) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.11 1.554 1.998 2.442 2.831 3.109 3.553 3.942 4.164 4.608 4.83 5.274 5.718 6.162 6.606 6.884 7.328" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">en anestesia general</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7086 178.2695) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 1.833 2.333" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Acción</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 178.3545) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.278 1.722 2.166 2.61 3.054 3.276 3.609 4.053 4.275 4.497 4.941 5.163 5.607 5.996 6.385 6.607 7.051 7.495 7.717 8.161 8.605 8.827 9.049 9.493 9.715 10.159 10.548 10.992 11.27 11.492 11.714 12.103 12.547 12.769 12.991 13.435 13.879 14.101 14.545 14.989 15.211 15.433 15.877 16.266 16.488 16.766 17.21 17.599 18.043 18.487 18.765 19.209 19.487 19.931 20.32 20.542 21.209 21.653 22.042 22.431 22.875 23.153 23.375 23.819 24.041 24.43 24.874 25.263 25.485 25.707 25.929 26.373 26.762 27.04 27.484 28.151 28.595 29.039 29.317 29.761 29.983 30.205 30.649 30.871 31.149 31.427 31.871 32.26 32.704 33.148 33.592 33.981 34.203 34.647 34.869 35.313 35.757 35.979 36.201 36.645 37.089 37.533 37.977" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Antagoniza la acción de la acetilcolina en los receptores muscarínicos. Incrementa la frecuencia del nodo </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 168.1545) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.611 1.055 1.499 1.888 2.332 2.554 2.776 3.165 3.387 3.665 4.109 4.498 4.72 4.942 5.164 5.442 5.886 6.108 6.33 6.774 6.996 7.385 7.829 8.273 8.717 9.161 9.55 9.939 10.161 10.605 11.049 11.271 11.715 12.159 12.381 12.825 13.047 13.269 13.713 14.157 14.601 15.045 15.267 15.711 16.155 16.433 16.655 17.044 17.488 17.71 18.154 18.432 18.821 19.265 19.709 19.987 20.265 20.487 20.876 21.32 21.542 21.986" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">sinusal y facilita la conducción en el nodo aurículo-ventricular</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7086 153.2846) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.778 1.278 1.778 2.056 2.556 3 3.222 3.666 4.166 4.666 5.166 5.666 6.166 6.666 6.999 7.221 7.721" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Efectos secundarios</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 153.3695) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.388 1.832 2.276 2.72 3.164 3.608 3.83 4.274 4.718 4.94 5.384 5.828 6.217 6.661 6.883 7.105 7.494 7.716 8.105 8.327 8.771 9.215 9.437 9.881 10.325 10.603 10.881 11.325 11.714 12.158 12.38 12.602 13.046 13.268 13.546 13.99 14.268 14.712 15.101 15.323 15.767 16.211 16.433 16.877 17.321 17.543 17.765 18.209 18.653 19.042 19.32 19.764 19.986 20.208 20.652 21.096 21.54 21.929 22.373 22.817 23.206 23.428 23.65 24.039 24.483 25.15 25.372 25.65 26.094 26.483 26.705 26.927 27.371 27.593 27.982 28.26 28.704 29.148 29.37 29.814 30.036 30.258 30.702 31.091 31.369 31.647 32.091 32.535 32.757 33.424 33.646 34.09 34.534 34.812 35.256 35.478 35.7 36.367 36.589 37.033 37.311 37.533 37.977 38.366 38.588 38.977 39.199" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Sequedad de boca, visión borrosa, alteración del gusto, náuseas, vómitos, disfagia, estreñimiento, midriasis, </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 143.1695) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 1 1.444 1.722 2.166 2.61 2.832 3.276 3.498 3.72 4.164 4.386 4.83 5.274 5.663 6.107 6.774 7.218 7.44 7.662 8.106 8.55 8.772 9.216 9.438 9.716 10.16 10.549 10.771 11.215 11.659 12.103 12.492 12.714 12.936 13.38 13.658 14.102 14.546 14.768 15.157 15.601 15.879 16.323 16.545 16.989 17.211 17.433 17.711 17.989 18.433 18.822 19.044 19.488 19.932 20.321 20.543 20.932 21.154 21.598 22.042 22.264 22.708 23.097 23.319 23.541 23.763 24.041 24.485 24.929 25.373 25.595 25.984 26.428 26.706 27.15 27.372 27.816 28.038 28.26 28.649 29.093 29.371 29.815 30.037 30.481 30.925 31.147 31.369 31.758 32.202 32.646 32.924 33.368 33.757 33.979 34.423 34.867 35.089 35.756 36.2 36.644 36.922 37.366 37.588 37.81 38.254" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">fotofobia, glaucoma, palpitaciones, bradicardia (tras dosis bajas), taquicardia, cefalea, confusión mental o </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 132.9695) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.833 1.222 1.444 1.722 2.166 2.555 2.777 3.221 3.665 3.887 4.109 4.553 4.942 5.386 5.83 6.219 6.441 6.885 7.107 7.774 8.218 8.662 8.94 9.384 9.606 10.05 10.494 10.716 11.16 11.604 11.993 12.215 12.659 13.103 13.547 13.936 14.158 14.38 14.602 14.991 15.435 16.102 16.546 16.99 17.212 17.656 18.1 18.489 18.711" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">excitación (especialmente en ancianos), somnolencia</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.7086 118.0995) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.056 1.556 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Interacciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 161.748 118.1856) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.111 1.778 2.222 2.611 3.055 3.444 3.666 4.11 4.554 4.832 5.054 5.443 5.887 6.109 6.331 6.775 7.219 7.497 7.941 8.163 8.552 8.996 9.385 9.607 9.829 10.273 10.717 10.995 11.217 11.661 12.105 12.383 12.772 12.994 13.438 13.827 14.271 14.715 14.937 15.381 15.825 16.269 16.658 16.88 17.102 17.546 17.99 18.268 18.49 18.934 19.156 19.545 19.823 20.267 20.934 21.156 21.6 21.822 22.211 22.655 23.044 23.266 23.488 23.951 24.395 24.673 25.117 25.561 26.005 26.672 26.894 27.116 27.56 27.782 28.004 28.504 28.726 29.004 29.448 29.892 30.17 30.392 30.836" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Fármacos anticolinérgicos, antiparkinsonianos, antihistamínicos. Verapamilo. Ritodrina</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.708904 101.3318) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.889 1.389 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111 5.555" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">Precauciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 76.708904 91.131799) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.944 1.444 1.944 2.444 2.666 3.166 3.388 3.888" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">especiales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 161.748 100.9111) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.596" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 169.02 101.0216) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.212 0.646 1.08 1.297 1.5093 1.8883 2.3223 2.6453 2.8576 3.2916 3.5039 3.7159 4.1499 4.5289 4.7409 5.1749 5.5539 5.9879 6.2002 6.6342 7.0682 7.3362 7.5482 7.9822 8.4162 8.6282 9.0072 9.2192 9.6532 9.8652 10.0775 10.5115 10.9455 11.1578 11.5918 11.8038 12.2378 12.6718 13.1058 13.5398 13.9738 14.3528 14.5651 15.1111 15.3791 15.8691 16.0814 16.5154 16.9494 17.1617 17.5407 17.9747 18.4087 18.8427 19.2767 19.7107 20.1447 20.357 20.791 21.059 21.493 21.927 22.361 22.5733 22.8413 23.0533 23.4873 23.9213 24.1336 24.3456 24.5576 24.7699 25.1489 25.3612 25.7952 26.2292 26.4415 26.6535 27.0875 27.4665 27.6788 28.1128 28.5468 28.7591 29.0271 29.4611 29.7291 30.1081 30.5421 30.8101 31.0224 31.4564 31.7244 32.1584 32.5924 33.0264 33.2387 33.6177 34.0517 34.4857 34.698 35.244 35.734 36.224 36.4363 36.8703 37.3043 37.6833 38.1173" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Ineﬁ caz e incluso perjudicial en bloqueos A-V de segundo grado tipo II y en los de tercer grado con QRS ancho</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 161.748 90.111) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 169.2 90.2215) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.055 1.499 1.943 2.61 2.832 3.276 3.498 3.887 4.165 4.443 4.887 5.276 5.498 5.942 6.386 6.608 7.052 7.496 7.718 8.162 8.606 8.995 9.217 9.606 9.828 10.495 10.939 11.383 11.827 12.105 12.549 12.938 13.16 13.604 14.048 14.492 14.714 15.158 15.38 15.824 16.046 16.713 17.157 17.379 17.823 18.267 18.711 19.155 19.599 19.821 20.265 20.543 20.987 21.431 21.875 22.264 22.486 22.764 22.986 23.43 23.874 24.096 24.54 24.818 25.262 25.651 25.929 26.373 26.595 27.039 27.483 27.761 28.205 28.649 29.093 29.315 29.537 29.926 30.37 30.592 30.981 31.203 31.425 31.647 32.091 32.535 32.979 33.257 33.479 33.923 34.145 34.589 34.978 35.422 35.866 36.144 36.588 37.032 37.31 37.532 37.754 38.198" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">La administración de dosis menores que 0,5 mg puede producir un efecto paradójico y llegar a acentuar la </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 170.2523 80.0215) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.722 1.166 1.61 1.832 2.221 2.665 2.943 3.387 3.609 4.053 4.275 4.719 5.163 5.607 5.829 6.218 6.662 6.884 7.328 7.606 8.05 8.328 8.772 9.216 9.66 10.104 10.326 10.715 11.159 11.437 11.715 12.159 12.603 12.825" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">bradicardia que se pretende corregir</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 72.3252 283.704) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.712 8.05 8.404 8.948 9.487 9.703 10.251" font-family="g_d0_f8" font-size="1px" fill="rgb(64,198,192)">Principio activo: atropina</svg:tspan></svg:text></svg:g></svg:g></svg:g></svg:svg>